X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3770) 3770
Publication (379) 379
Book Chapter (164) 164
Book Review (73) 73
Reference (31) 31
Dissertation (17) 17
Conference Proceeding (6) 6
Book / eBook (3) 3
Government Document (3) 3
Magazine Article (3) 3
Web Resource (2) 2
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1859) 1859
selective serotonin reuptake inhibitors (1613) 1613
index medicus (1414) 1414
male (1227) 1227
female (1129) 1129
psychiatry (1103) 1103
pharmacology & pharmacy (1087) 1087
selective serotonin reuptake inhibitor (966) 966
antidepressants (911) 911
depression (887) 887
neurosciences (773) 773
adult (741) 741
animals (706) 706
serotonin uptake inhibitors - therapeutic use (679) 679
serotonin (658) 658
fluoxetine (645) 645
middle aged (560) 560
clinical neurology (452) 452
serotonin uptake inhibitors - adverse effects (440) 440
serotonin uptake inhibitors (425) 425
paroxetine (420) 420
serotonin uptake inhibitors - pharmacology (419) 419
serotonin reuptake inhibitors (406) 406
double-blind (403) 403
rats (359) 359
aged (356) 356
treatment outcome (353) 353
major depression (350) 350
antidepressive agents - therapeutic use (315) 315
major depressive disorder (313) 313
citalopram (306) 306
antidepressant (298) 298
adolescent (293) 293
anxiety (289) 289
sertraline (279) 279
drug therapy (275) 275
depressive disorder - drug therapy (256) 256
tricyclic antidepressants (255) 255
analysis (250) 250
dose-response relationship, drug (243) 243
depressive disorder, major - drug therapy (241) 241
risk factors (229) 229
selective serotonin (227) 227
depression, mental (226) 226
serotonin uptake inhibitors - administration & dosage (216) 216
depression - drug therapy (214) 214
double-blind method (207) 207
efficacy (202) 202
risk (202) 202
article (201) 201
phenols (201) 201
fluvoxamine (195) 195
obsessive-compulsive disorder (191) 191
antidepressive agents - adverse effects (189) 189
care and treatment (181) 181
young adult (181) 181
brain (171) 171
drugs (170) 170
serotonin - metabolism (170) 170
research (169) 169
pregnancy (163) 163
citalopram - pharmacology (161) 161
time factors (159) 159
children (157) 157
mice (155) 155
rats, sprague-dawley (155) 155
ssri (154) 154
antidepressive agents - pharmacology (150) 150
psychiatric status rating scales (146) 146
health aspects (145) 145
child (144) 144
fluoxetine - pharmacology (144) 144
mental disorders (141) 141
drug interactions (140) 140
citalopram - therapeutic use (139) 139
psychology (139) 139
mental depression (137) 137
metaanalysis (137) 137
placebo-controlled trial (134) 134
reuptake inhibitors (134) 134
serotonin transporter (128) 128
dopamine (126) 126
medicine & public health (125) 125
placebo (125) 125
escitalopram (123) 123
dosage and administration (121) 121
neurology (121) 121
pharmacotherapy (121) 121
panic disorder (119) 119
venlafaxine (119) 119
pharmacology (118) 118
rat-brain (118) 118
disorder (116) 116
prevalence (113) 113
antidepressive agents, second-generation - therapeutic use (109) 109
retrospective studies (109) 109
pediatrics (108) 108
brain - drug effects (107) 107
therapy (106) 106
biochemistry & molecular biology (105) 105
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3758) 3758
German (61) 61
French (50) 50
Japanese (32) 32
Spanish (16) 16
Russian (15) 15
Portuguese (12) 12
Italian (8) 8
Polish (8) 8
Chinese (6) 6
Dutch (5) 5
Czech (3) 3
Icelandic (3) 3
Korean (3) 3
Arabic (1) 1
Croatian (1) 1
Danish (1) 1
Hungarian (1) 1
Slovenian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Psychotherapy and Psychosomatics, ISSN 0033-3190, 03/2015, Volume 84, Issue 2, pp. 72 - 81
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 12/2003, Volume 95, Issue 23, pp. 1758 - 1764
Tamoxifen, a selective estrogen receptor modulator (SERM), is converted to 4-hydroxy-tamoxifen and other active metabolites by cytochrome P450 (CYP) enzymes.... 
Cytochrome P-450 CYP2D6 Inhibitors | Paroxetine - pharmacokinetics | Serotonin Uptake Inhibitors - pharmacokinetics | Prospective Studies | Cytochrome P-450 Enzyme Inhibitors | Selective Estrogen Receptor Modulators - pharmacokinetics | Antineoplastic Combined Chemotherapy Protocols - blood | Cytochrome P-450 CYP3A | Humans | Microsomes, Liver - metabolism | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - pharmacokinetics | Tamoxifen - administration & dosage | Antineoplastic Agents, Hormonal - pharmacokinetics | Paroxetine - administration & dosage | Paroxetine - blood | Breast Neoplasms - enzymology | Adult | Female | Serotonin Uptake Inhibitors - blood | Chemotherapy, Adjuvant | Antineoplastic Agents, Hormonal - administration & dosage | Enzyme Inhibitors - pharmacology | Tamoxifen - blood | Selective Estrogen Receptor Modulators - administration & dosage | Treatment Outcome | Tamoxifen - pharmacokinetics | Breast Neoplasms - drug therapy | Antineoplastic Agents, Hormonal - blood | Selective Estrogen Receptor Modulators - blood | Serotonin Uptake Inhibitors - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - blood | Tamoxifen - analogs & derivatives | Aged | PERFORMANCE LIQUID-CHROMATOGRAPHY | BREAST-CANCER | MAJOR METABOLITES | ONCOLOGY | 4-HYDROXYLATION | RANDOMIZED CONTROLLED-TRIAL | HUMAN LIVER-MICROSOMES | CYP2D6 ACTIVITY | HOT FLASHES | CYTOCHROME-P450 2D6 | VENLAFAXINE | Paroxetine | Evaluation | Serotonin uptake inhibitors | Tamoxifen
Journal Article
Gut, ISSN 0017-5749, 08/2006, Volume 55, Issue 8, pp. 1095 - 1103
Journal Article
American Journal of Kidney Diseases, ISSN 0272-6386, 10/2019
Journal Article
Journal Article
Journal Article
Journal Article